APELLIS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42 USD | +0.19% |
|
-1.22% | -29.84% |
Chart calendar Apellis Pharmaceuticals, Inc.
252f14188ae97550cb.EV7FiswkZqj3DD9MU2SOkBFUwm7qGwwR6_Z2iYp3sR4.VGiuy_4dL56fZFk-fjb65CAaqjuZdVo8pKVOuMMT2E95L4b5r3Eh0sF9UA~0b9da5942584d4c316fabc0c724044b3
Upcoming events on Apellis Pharmaceuticals, Inc.
Past events on Apellis Pharmaceuticals, Inc.
| 2024-05-14 11:00 am | BofA Securities Health Care Conference |
| 2024-05-09 06:30 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-09 06:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-09 05:30 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-09 05:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-09 11:00 am | Association for Research in Vision and Ophthalmology Meeting - Deep learning-based segmentation |
| 2024-05-09 11:00 am | Association for Research in Vision and Ophthalmology Meeting - MOSAIC study |
| 2024-05-07 05:30 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-07 05:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-07 12:30 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-07 08:30 am | Q1 2024 Earnings Call |
| 2024-05-07 07:05 am | Q1 2024 Earnings Release |
| 2024-05-06 06:00 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-06 11:30 am | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-05 07:45 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-05 05:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-05-05 04:45 pm | Association for Research in Vision and Ophthalmology Meeting |
| 2024-04-08 12:45 pm | Needham Healthcare Conference |
| 2024-03-05 11:00 am | Raymond James Institutional Investors Conference - Fireside Chat |
| 2024-03-05 09:10 am | TD Cowen Health Care Conference - Panel |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 251 98,4 154.61% | 66,6 15,0 343.57% | 75,4 77,7 -2.87% | 397 392 1.15% | 822 |
|
EBITDA Million USD | Released Forecast Spread | -288 -247 -16.61% | -213 -377 43.41% | -535 -560 4.52% | -593 -587 -0.96% | -515 -521 1.07% | -84,1 |
|
EBIT Million USD | Released Forecast Spread | -288 -255 -13.08% | -214 -373 42.68% | -536 -580 7.58% | -595 -590 -0.7% | -517 -513 -0.8% | -98,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -305 -263 -15.69% | -343 -449 23.62% | -746 -736 -1.29% | -652 -660 1.3% | -526 -523 -0.69% | -108 |
|
Net income Million USD | Released Forecast Spread | -305 -264 -15.43% | -345 -458 24.78% | -746 -724 -3.12% | -652 -660 1.17% | -529 -525 -0.72% | -109 |
|
EPS USD | Released Forecast Spread | -4,90 -4,23 -15.73% | -4,59 -5,95 22.84% | -8,84 -8,66 -2.06% | -6,15 -6,27 1.97% | -4,45 -4,44 -0.23% | -0,89 |
| Announcement Date | 27/02/20 | 25/02/21 | 28/02/22 | 21/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,4 12,6 13.94% | 16,3 16,9 -3.68% | 22,1 21,6 2.15% | 22,7 24,5 -7.57% | 44,8 26,1 71.79% | 95,0 71,1 33.53% | 110 99,1 11.45% | 146 144 1.94% | 172 164 4.91% | 193 | 217 | 241 | 255 | 279 |
|
EBITDA Million USD | Released Forecast Spread | -129 -105 -22.42% | -148 -116 -27.69% | -153 -126 -20.75% | -164 -134 -21.73% | -175 -155 -13.01% | -120 -149 19.59% | -137 -93,0 -46.86% | -84,0 -102 17.53% | -54,7 | -29,8 | -9,84 | 9,97 | ||
|
EBIT Million USD | Released Forecast Spread | -129 -129 -0.03% | -149 -138 -7.82% | -153 -151 -1.28% | -164 -154 -6.55% | -175 -169 -3.46% | -120 -153 21.44% | -137 -114 -19.81% | -84,5 -79,5 -6.29% | -62,1 -58,5 -6.07% | -31,2 | -11,4 | 11,3 | 32,8 | 45,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -138 -126 -9.08% | -155 -141 -9.95% | -191 -157 -21.16% | -167 -162 -3.31% | -177 -163 -8.97% | -122 -151 19.54% | -140 -99,7 -40.4% | -87,2 -76,3 -14.27% | -66,3 -54,4 -21.83% | -34,7 | -14,2 | 8,89 | 29,1 | 42,7 |
|
Net income Million USD | Released Forecast Spread | -139 -130 -6.95% | -156 -144 -8.28% | -191 -158 -20.8% | -166 -172 3.51% | -178 -165 -7.56% | -122 -153 20.37% | -140 -103 -36.48% | -88,6 -79,7 -11.1% | -66,4 -54,3 -22.21% | -35,0 | -14,8 | 7,01 | 27,8 | 41,3 |
|
EPS USD | Released Forecast Spread | -1,42 -1,30 -8.91% | -1,46 -1,37 -6.42% | -1,75 -1,46 -19.61% | -1,50 -1,56 4.1% | -1,56 -1,46 -6.78% | -1,02 -1,32 22.67% | -1,17 -0,86 -36.15% | -0,73 -0,69 -6.41% | -0,54 -0,45 -19.48% | -0,29 | -0,12 | 0,05 | 0,10 | 0,23 |
| Announcement Date | 04/05/22 | 08/08/22 | 07/11/22 | 21/02/23 | 04/05/23 | 31/07/23 | 01/11/23 | 27/02/24 | 07/05/24 | - | - | - | - | - |
| 2024-07-11 02:00 am | BONESUPPORT HOLDING AB: Q2 2024 Earnings Release |
| 2024-07-15 | SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release |
| 2024-07-22 | BIOGEN INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 02:00 am | BIOGAIA AB: Q2 2024 Earnings Release |
| 2024-07-23 | SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected) |
| 2024-07-25 01:00 am | UCB: Q2 2024 Earnings Release |
| 2024-07-25 | SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Apellis Pharmaceuticals, Inc.
| 2024-05-14 11:35 am | GRIFOLS, S.A.: Q1 2024 Earnings Release |
| 2024-05-12 | ALTEOGEN INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-09 | MEDY-TOX INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 02:30 am | NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-08 | HUGEL, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:16 pm | CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-08 04:05 pm | ZAI LAB LIMITED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APLS Stock
- Calendar Apellis Pharmaceuticals, Inc.
